Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Coverage Resumed on Canadian Producer Following Acquisition

A review of the transaction and its implications are provided in a BMO Capital Markets report. In a Feb. 3 research note, analyst Brian Quast reported that BMO Capital Markers resumed coverage and lowered its target price on Kirkland Lake Gold Inc. (KL:TSX;...
Streetwise Reports | February 7, 2020 |

Coverage Initiated on Cancer Vaccine Firm

An H.C. Wainwright & Co. report explained the reasons for its "bullish view" on this California-based life sciences company. In a March 7 research note, analyst Swayampakula Ramakanth reported that H.C. Wainwright & Co. initiated coverage on Gritstone Oncology Inc. (GR...
Streetwise Reports | March 11, 2019 |

Zacks Small-Cap Research initiates coverage of Medicus Pharma (TSXV:MDCX)

Click here to download the report. This is third-party provided content issued on behalf of Medicus Pharma Ltd. (TSXV:MDCX) , please see full disclaimer here . Join the discussion: Find out what everybody’s saying about this stock on ...
Research | January 10, 2024 |

Coverage Initiated on Developer of Neurodegenerative Disease Therapeutics

An H.C. Wainwright & Co. report presented the investment bank's reasons for its bullish view on this California-based biotech. In a June 26 research note, analyst Andrew Fein reported that H.C. Wainwright & Co. initiated coverage on Denali Therapeutics ...
Streetwise Reports | July 3, 2019 |

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...
Marc Davis | May 10, 2021 |

Explorer With 'Highly Undervalued Stock' Increases Project Resource

The report updates and the company being a takeout target are discussed in an iA Securities report. In a Jan. 7 research note, iA Securities analyst George Topping reported that Rubicon Minerals Corp. (RMX:TSX; RBYCF:OTCMKTS) updated the mineral resource at its Phoe...
Streetwise Reports | January 15, 2020 |

Gold Producer's PEA 'Firms Up Growth Potential'

The contents of the report on Fiore Gold's Nevada project are reviewed by Mackie Research Capital Corp. In an April 9 research note, Mackie Research Capital Corp. analyst Stuart McDougall reported that Fiore Gold Ltd. (F:TSX.V; FIOGF:OTCQB) released a prel...
Streetwise Reports | April 15, 2020 |

Coverage Initiated on 'Unique Silver Exploration Story'

The rationale for investing in this Canadian mining company is given in this BMO Capital Markets report. Silver Sand In an Aug. 13 research note, analyst Ryan Thompson reported that BMO Capital Markets initiated coverage on New Pacific Metals Corp. ...
Streetwise Reports | August 20, 2019 |

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Co

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary Source: Gail Dutton of The Life Sciences Report (12/22/15) https://www.thelifesciencesreport.com/pub/na/aethlon-medical...
Gail Dutton | December 23, 2015 |

Target Price Increased on Oil & Gas Company 'Poised for Continued Growth'

A Raymond James report provided reasons for the upward revision and detailed areas of potential growth for this Texas-based entity. In a March 8 research note, analyst John Freeman reported that Raymond James increased its target price to $24 per share from $22 and reit...
Streetwise Reports | March 15, 2019 |
1 2 3 4 5 6 7 8 9 10 ...